Multiple Myeloma/Plasma Cell Neoplasms - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005, Updated: 04/21/2015) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.
- Treating Patients with High-Risk Smoldering Myeloma
(Posted: 12/11/2012) - In this phase III clinical trial, patients with smoldering myeloma classified as high risk for progression will be randomly assigned to undergo standard observation or six 4-week courses of treatment with the drug lenalidomide.